Longmont, Colorado, July 19, 2017 -- Lightwave Logic, Inc. (OTCQB: LWLG), a technology company focused on the development of Next Generation Photonic Devices and Non-Linear Optical Polymer Materials Systems for applications in high-speed fiber-optic data communications and telecommunications, announced today it has advanced its high-speed modulation performance to satisfy 28Gbps data rates for QSFP28 standards and 100Gbps data center applications.
|
|||
A modulator device is used in front of a laser diode to modulate the light into very high-speed digital pulses that traverse fiber optic cables. Modulation is the central information-encoding technology for the data center, data-communications, and high-performance computing industries. Modulators for QSFP28 (28Gbps) are typically operated in parallel using 4 channels at 28Gbps (which is 3Gbps faster than 25Gbps) to achieve 100Gbps overall performance with the extra 12Gbps (4 channels of 3Gbps) to allow for sufficient information encoding overhead as required by standards such as the QSFP 28 protocol (SFF-8665), as well as IEEE 802 protocols such as: CEI-28G-VSR/SR/MR/LR; zSFP+ which are more commonly known as SFP28 (SFF-8402); 32GFC with SFP-28LR (SFF-8432) as examples.
Lightwave’s Polymer Photonics Integrated Circuit (P2ICTM) is analogous to an electronic integrated circuit but incorporates two or more optical functions or devices integrated onto a single substrate platform. We expect P2ICsTM to become a key engine in the transceiver market over the next decade.
Michael Lebby, CEO of Lightwave Logic commented, “We are continually improving the performance of our modulators as per our development plan and are on schedule to further increase the performance of our ridge waveguide modulator in the coming months. Our team has grown in both size and experience to further support the advancement of our polymer P2ICTM Polymer PIC (photonic integrated circuit) platform technology and this will help accelerate our progress. The improved performance of this prototype puts us on the right track to further scale our ridge waveguide modulator towards 50Gbps, which will enable 400Gbps optical networking data-rates (using 4 channels at 50Gbps with PAM4 modulation - to double the speed, or 8 channels at 50Gbps using NRZ modulation).
"As we further understand the dynamics of the data communications market, we see that we are positioning Lightwave to become a leading technology provider for integrated photonics devices and platforms at 25Gbps and beyond.
“We continue our laser-like focus for the remainder of 2017 to hone the performance of our polymer ridge waveguide modulator for prototyping. Achieving higher data rates that exceed 25Gbps opens the doors to more opportunities at 100Gbps, which will allow us to address the burgeoning demand for 400 Gbps and higher performance opportunities with a cost-effective scalable technology alternative.”
Powered by Lightwave Logic
Lightwave Logic, Inc. is a development stage company moving toward commercialization of next generation photonic devices using its high-activity and high-stability organic polymers for applications in data communications and telecommunications markets. Photonic electro-optical devices convert data from electric signals into optical signals. For more information, about the Company please visit the corporate website at www.lightwavelogic.com.
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, lack of available funding; general economic and business conditions; competition from third parties; intellectual property rights of third parties; regulatory constraints; changes in technology and methods of marketing; delays in completing various engineering and manufacturing programs; changes in customer order patterns; changes in product mix; success in technological advances and delivering technological innovations; shortages in components; production delays due to performance quality issues with outsourced components; those events and factors described by us in Item 1.A “Risk Factors” in our most recent Form 10-K; other risks to which our Company is subject; other factors beyond the Company's control.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/80560c2e-fad6-4425-afad-5476cd64e0ad
Steven Cordovano Lightwave Logic 203-952-6373 [email protected]


Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



